LIBERTY
Liberty Star issues a discounted promissory note
Liberty Star issued a $95,700 debt instrument with an 8% interest rate to Monroe Street Capital Partners that cannot be prepaid for one year....
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Stewards,
Stewards enters USD agreement to purchase Envy Pompano Beach project
Stewards signed a definitive agreement to acquire real property interests in Pompano Beach, Florida, from sellers Envy Development PB and The Myelin G...
URANIUM
UEC Fiscal-2026 Production Up 157%
UEC produced 229,294 lbs of uranium in FY2026, doubling output at Christensen Ranch, and delivered a peer-leading realized price of $93.13 per pound, ...
NVDA
MongoDB, Kodiak Sciences, Navitas Semiconductor, Boeing and Nvidia: Why These 5 Stocks Are on Investors' Radars Today
MongoDB, Kodiak Sciences, Navitas Semiconductor, Boeing and Nvidia: Why These 5 Stocks Are on Investors' Radars Today...
GS
Goldman Sachs Board Reportedly Discussed Plan for CEO David Solomon to Step Down, Hand the Top Job to President John Waldron
Goldman Sachs Board Reportedly Discussed Plan for CEO David Solomon to Step Down, Hand the Top Job to President John Waldron...
MSFT
Reported September 28, 'OpenAI Scraps Release of New AI Model Over Safety Concerns' - WSJ Exclusive
Reported September 28, 'OpenAI Scraps Release of New AI Model Over Safety Concerns' - WSJ Exclusive...
META
Alexandr Wang Praises Meta's Muse for Tackling an Everyday Neighborhood Problem: 'Seriously Awesome Use Case'
Alexandr Wang Praises Meta's Muse for Tackling an Everyday Neighborhood Problem: 'Seriously Awesome Use Case'...
TSLA
Anthropic Bets Big On AI, Bleeds Billions: Key Details From The Reported IPO Prospectus
Anthropic Bets Big On AI, Bleeds Billions: Key Details From The Reported IPO Prospectus...
MRK
Cyprumed's Oral Peptide Tablet Technology Enters Human Clinical Development As MSD Initiates Phase I Trial, Triggering Milestone Payment For Up To $493M From MSD
Cyprumed's Oral Peptide Tablet Technology Enters Human Clinical Development As MSD Initiates Phase I Trial, Triggering Milestone Payment For Up To $49...
BA
NASA Chief Gives Boeing Starliner Second Chance After 2024 Mishap — Uncrewed Flight Could Come By Early 2027: ‘Fastest Path to Preserving Reliable Crewed Access’ to LEO
NASA Chief Gives Boeing Starliner Second Chance After 2024 Mishap — Uncrewed Flight Could Come By Early 2027: ‘Fastest Path to Preserving Reliable Cre...
MU
Micron Is in the ‘Best Cycle Anyone’ Has Ever Seen — MU Stock Is ‘in a Bubble,’ But Bulls Can Still Profit, Says Analyst
Micron Is in the ‘Best Cycle Anyone’ Has Ever Seen — MU Stock Is ‘in a Bubble,’ But Bulls Can Still Profit, Says Analyst...
BA
Boeing 737 MAX 10 Certification Delayed Over New Software Issue
Boeing 737 MAX 10 Certification Delayed Over New Software Issue...
AZN
Summit Therapeutics Soars Nearly 20% After AstraZeneca Bets $2 Billion on Cancer Drug Ivonescimab
Summit Therapeutics Soars Nearly 20% After AstraZeneca Bets $2 Billion on Cancer Drug Ivonescimab...
TSLA
Anthropic Eyes Monster $2 Trillion IPO, Yet Deal Veteran Says It Won’t Be a Market Catalyst
Anthropic Eyes Monster $2 Trillion IPO, Yet Deal Veteran Says It Won’t Be a Market Catalyst...
CAT
Caterpillar To Acquire The Fabick Chain Of Equipment Dealers With A Presence Across Four Midwestern States; Terms Not Disclosed
Caterpillar To Acquire The Fabick Chain Of Equipment Dealers With A Presence Across Four Midwestern States; Terms Not Disclosed...
JNJ
Johnson & Johnson To Present New Findings On IMAAVY For Treatment Of Generalized Myasthenia Gravis Across 15 Novel Abstracts At 2026 MGFA Scientific Session And AANEM Annual Meeting
Johnson & Johnson To Present New Findings On IMAAVY For Treatment Of Generalized Myasthenia Gravis Across 15 Novel Abstracts At 2026 MGFA Scientific S...
NKE
RBC Capital Maintains Sector Perform on Nike, Lowers Price Target to $40
RBC Capital Maintains Sector Perform on Nike, Lowers Price Target to $40...
WMT
Mizuho Maintains Outperform on Walmart, Lowers Price Target to $125
Mizuho Maintains Outperform on Walmart, Lowers Price Target to $125...
GS
Goldman Sachs Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Goldman Sachs Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call...
JNJ
JP Morgan Maintains Neutral on Johnson & Johnson, Raises Price Target to $285
JP Morgan Maintains Neutral on Johnson & Johnson, Raises Price Target to $285...